{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:02:23Z","timestamp":1791234143770,"version":"4.1.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11,24]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The contributions of the host microenvironment to the pathogenesis of multiple myeloma, including progression from the non-malignant disorder monoclonal gammopathy of undetermined significance, are poorly understood. In the present study, microarray analysis of a murine model requiring a unique host microenvironment for myeloma development identified decreased host-derived adiponectin compared with normal mice. In support, clinical analysis revealed decreased serum adiponectin concentrations in monoclonal gammopathy of undetermined significance patients who subsequently progressed to myeloma. We investigated the role of adiponectin in myeloma pathogenesis and as a treatment approach, using both mice deficient in adiponectin and pharmacologic enhancement of circulating adiponectin. Increased tumor burden and bone disease were observed in myeloma-bearing adiponectin-deficient mice, and adiponectin was found to induce myeloma cell apoptosis. The apolipoprotein peptide mimetic L-4F was used for pharmacologic enhancement of adiponectin. L-4F reduced tumor burden, increased survival of myeloma-bearing mice, and prevented myeloma bone disease. Collectively, our studies have identified a novel mechanism whereby decreased host-derived adiponectin promotes myeloma tumor growth and osteolysis. Furthermore, we have established the potential therapeutic benefit of increasing adiponectin for the treatment of myeloma and the associated bone disease.<\/jats:p>","DOI":"10.1182\/blood-2011-01-330407","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T02:51:56Z","timestamp":1315623116000},"page":"5872-5882","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":125,"title":["Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease"],"prefix":"10.1182","volume":"118","author":[{"given":"Jessica A.","family":"Fowler","sequence":"first","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Cancer Biology, Vanderbilt University, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seint T.","family":"Lwin","sequence":"additional","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN;"},{"name":"Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Drake","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, College of Medicine, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN;"},{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Mundy","sequence":"additional","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Cancer Biology, Vanderbilt University, Nashville, TN;"},{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN;"},{"name":"Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom;"},{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111808433562600_B1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2019111808433562600_B2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2010.06.029","article-title":"Tumor-host cell interactions in the bone disease of myeloma.","volume":"48","author":"Fowler","year":"2010","journal-title":"Bone"},{"issue":"3","key":"2019111808433562600_B3","first-page":"593","article-title":"Animal model of human disease: multiple myeloma.","volume":"132","author":"Radl","year":"1988","journal-title":"Am J Pathol"},{"issue":"2","key":"2019111808433562600_B4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.122.2.609","article-title":"Idiopathic paraprotienemia: II. Transplantation of the paraprotein-producing clone from old to young C587Bl\/KaLwRij mice.","volume":"122","author":"Radl","year":"1979","journal-title":"J Immunol"},{"issue":"11","key":"2019111808433562600_B5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1242\/dmm.003160","article-title":"A murine model of myeloma that allows genetic manipulation of the host microenvironment.","volume":"2","author":"Fowler","year":"2009","journal-title":"Dis Model Mech"},{"issue":"6","key":"2019111808433562600_B6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S8756-3282(97)00056-2","article-title":"A murine model of human myeloma bone disease.","volume":"20","author":"Garrett","year":"1997","journal-title":"Bone"},{"issue":"4","key":"2019111808433562600_B7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","article-title":"Adiponectin and its receptors are expressed in bone-forming cells.","volume":"35","author":"Berner","year":"2004","journal-title":"Bone"},{"issue":"15","key":"2019111808433562600_B8","first-page":"5699","article-title":"Association of serum adiponectin levels with breast cancer risk.","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2019111808433562600_B9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ncpendmet0456","article-title":"Mechanisms of disease: adipokines and breast cancer: endocrine and paracrine mechanisms that connect adiposity and breast cancer.","volume":"3","author":"Schaffler","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"2019111808433562600_B10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2006.04.076","article-title":"Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells.","volume":"345","author":"Dieudonne","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2019111808433562600_B11","doi-asserted-by":"crossref","first-page":"e4968","DOI":"10.1371\/journal.pone.0004968","article-title":"Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities.","volume":"4","author":"Lam","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"2019111808433562600_B12","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/1078-0432.CCR-08-2661","article-title":"Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.","volume":"15","author":"Denzel","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2019111808433562600_B13","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1158\/1078-0432.CCR-08-2649","article-title":"Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.","volume":"15","author":"Landskroner-Eiger","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2019111808433562600_B14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V93.5.1697","article-title":"Ibandronate reduces osteolytic lesions but not tumour burden in a murine model of myeloma bone disease.","volume":"93","author":"Dallas","year":"1999","journal-title":"Blood"},{"issue":"5","key":"2019111808433562600_B15","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1182\/blood-2007-03-077685","article-title":"Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.","volume":"111","author":"Edwards","year":"2008","journal-title":"Blood"},{"issue":"17","key":"2019111808433562600_B16","first-page":"4996","article-title":"Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.","volume":"62","author":"LeBlanc","year":"2002","journal-title":"Cancer Res"},{"issue":"22","key":"2019111808433562600_B17","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111808433562600_B18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc06-1362","article-title":"Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays.","volume":"30","author":"Bluher","year":"2007","journal-title":"Diabetes Care"},{"issue":"9","key":"2019111808433562600_B19","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/oby.2006.174","article-title":"High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects.","volume":"14","author":"Salani","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"2019111808433562600_B20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation.","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"issue":"6941","key":"2019111808433562600_B21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"issue":"1","key":"2019111808433562600_B22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"2019111808433562600_B23","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.yexcr.2007.06.020","article-title":"Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.","volume":"313","author":"Baumann","year":"2007","journal-title":"Exp Cell Res"},{"issue":"6","key":"2019111808433562600_B24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-09-1805","article-title":"Metformin: a therapeutic opportunity in breast cancer.","volume":"16","author":"Gonzalez-Angulo","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2019111808433562600_B25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2010.06.052","article-title":"AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival.","volume":"398","author":"Woodard","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2019111808433562600_B26","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1194\/jlr.M800046-JLR200","article-title":"L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice.","volume":"49","author":"Peterson","year":"2008","journal-title":"J Lipid Res"},{"issue":"8","key":"2019111808433562600_B27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111808433562600_B28","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin: implications for metabolic regulation and bioactivity.","volume":"278","author":"Pajvani","year":"2003","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111808433562600_B29","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1210\/jc.2004-0303","article-title":"Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels.","volume":"89","author":"Bottner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2019111808433562600_B30","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1074\/jbc.M414231200","article-title":"Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes.","volume":"280","author":"Xu","year":"2005","journal-title":"J Biol Chem"},{"issue":"5","key":"2019111808433562600_B31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-0609.2009.01311.x","article-title":"Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma.","volume":"83","author":"Reseland","year":"2009","journal-title":"Eur J Haematol"},{"issue":"2","key":"2019111808433562600_B32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"7","key":"2019111808433562600_B33","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1055-9965.EPI-07-0143","article-title":"Body mass index, physical activity, and risk of multiple myeloma.","volume":"16","author":"Birmann","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019111808433562600_B34","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance (MGUS) among African-American and Caucasian women.","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111808433562600_B35","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1194\/jlr.P800003-JLR200","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.","volume":"49","author":"Bloedon","year":"2008","journal-title":"J Lipid Res"},{"issue":"8","key":"2019111808433562600_B36","doi-asserted-by":"crossref","first-page":"e11987","DOI":"10.1371\/journal.pone.0011987","article-title":"Adiponectin deficiency promotes tumor growth in mice by reducing macrophage infiltration.","volume":"5","author":"Sun","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"2019111808433562600_B37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","article-title":"Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.","volume":"331","author":"Oshima","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2019111808433562600_B38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1574-695X.2006.00164.x","article-title":"Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans.","volume":"49","author":"Yamaguchi","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"2019111808433562600_B39","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/en.2008-1639","article-title":"In vitro and in vivo effects of adiponectin on bone.","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"},{"key":"2019111808433562600_B40","article-title":"Increases in serum levels of Dickkopf 1 are associated with alterations in skeletal microstructure in monoclonal gammopathy of undetermined significance [abstract].","volume":"24","author":"Drake","year":"2009","journal-title":"J Bone Miner Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/22\/5872\/1345411\/zh804811005872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/22\/5872\/1345411\/zh804811005872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T10:27:10Z","timestamp":1686306430000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/22\/5872\/29171\/Hostderived-adiponectin-is-tumorsuppressive-and-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,24]]},"references-count":40,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2011,11,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-330407","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,24]]}}}